Gilde Healthcare’s Financing of Its Acquisition of Sanquin Reagents

Giulia Di Palma
Tagged:

Clifford Chance advised specialised healthcare investor Gilde Healthcare on the deal.Gilde Healthcare, a specialized healthcare investor, today announces its intention to acquire Sanquin Reagents from Sanquin…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Giulia Di Palma

Author: Giulia Di Palma

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here